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Letter to the Editor
To the Editor, Neonatal herpes simplex virus (HSV) is often a devastating disease especially if acquired after a primary maternal infection. Up to 80% of mothers are unaware of their positive herpetic status. Disseminated disease carries the highest mortality with up to 77% death rate after diagnosis. Patients may present with minimal symptoms, such as only fever as in our case, or with central nervous system manifestations and sepsis. 1 Rarely, HSV infections may trigger underlying inherited immune dysfunction with devastating effect.
Hemophagocytic lymphohistiocytosis (HLH) is a lifethreatening syndrome characterized by a reactive process resulting from prolonged and excessive activation of immune cells. The predominant clinical findings include fevers, cytopenias, hepatitis, and splenomegaly.
2 Multi-organ failure and death are likely if HLH is unrecognized or insufficiently treated. 3 We present a neonate diagnosed with disseminated neonatal HSV-2 infection and extreme hyperferritinemia who was treated for HLH, but died of multi-organ failure.
Our patient was a term male born via Caesarian section to a mother with endometritis. He was admitted with a fever of 101.7°F on the sixth day of life. Ampicillin and cefotaxime were started empirically. He quickly became lethargic with elevated liver function tests, at which time high-dose acyclovir was added. Initial blood counts were normal but severe pancytopenia evolved (Figure 1) . He also developed feeding intolerance, hypothermia, and bradycardia with renal, hepatic, and respiratory failure. Blood HSV-2 polymerase chain reaction showed >2 000 000 copies/mL, but cerebrospinal fluid HSV polymerase chain reaction was negative. Disseminated intravascular coagulation and hepatomegaly without splenomegaly were noted. He initially fulfilled only 4 criteria of HLH diagnosis including ferritin >100 000 µg/L, fever, cytopenias, and hypofibrinogenemia. 4 Bone marrow did not reveal hemophagocytosis or leukemia. Soluble IL-2 and NK cell activity resulted within normal limits.
Dexamethasone was started and etoposide was added later to empirically treat suspected HLH. Multi-organ failure worsened despite maximal support and he died 15 days after admission. Molecular studies for familial HLH revealed variants of unknown significance in 2 of the genes with reference sequences LYST (NM_000081.2) and ITK (NM_005546.3). Family declined an autopsy.
Disseminated neonatal HSV is usually fatal despite appropriate treatment. 4 Some cases trigger exaggerated inflammatory response that cannot be distinguished from HLH even if elevated ferritin level greater than 10 000 µg/L is more than 90% sensitive and 96% specific for HLH. 5 Untreated HLH is equally dangerous and is hard to diagnose. 2, 6 Also, it is not easy to justify the use of anticytokine therapy in presence of disseminated neonatal HSV. Maeba et al successfully treated neonatal HSV and HLH using a combination of antiviral therapy and methylprednisolone. 7 Otsubo et al also treated a neonate with HSV complicated by HLH with dexamethasone palmitate successfully. 8 In contrast, we utilized a combination of antiviral and conventional HLH therapy.
Vladescu et al highlight the conundrum of diagnosis and treatment of HLH in neonates with confirmed disseminated HSV infection and massive hyperferritinemia. 9 These neonates typically experienced a complex life-threatening course with multi-organ failure. The resulting paradox is extremely challenging and decision of starting HLH treatment should be considered on a case by case basis to avoid unnecessary immunosuppression.
